Who is sponsoring NCT04802941?

NCT04802941 is sponsored by Center of Personalized Medicine, Pirogova.

What drugs are being tested in NCT04802941?

Interventions in NCT04802941: Neoadjuvant Chemotherapy by CDSS (MedicBK), General practice.

What condition does NCT04802941 study?

NCT04802941 studies Decision Support Systems, Clinical.

Is NCT04802941 still recruiting?

NCT04802941 is currently status unknown. Last updated 18 March 2021.

Last reviewed 2021-03-18 · How we verify

NCT04802941

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Neoadjuvant Chemotherapy in Breast Cancer

Status unknown NA Last updated 18 March 2021

What this trial tests

NA trial testing Neoadjuvant Chemotherapy by CDSS (MedicBK) in Decision Support Systems, Clinical in 1,200 participants. Status unknown.

Timeline

12 March 2021

Primary endpoint
30 March 2024

30 March 2024

Quick facts

Lead sponsor	Center of Personalized Medicine, Pirogova
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	1,200
Start date	12 March 2021
Primary completion	30 March 2024
Estimated completion	30 March 2024
Sites	1 location across Russia

Drugs / interventions tested

Neoadjuvant Chemotherapy by CDSS (MedicBK)
General practice — full drug profile →

Conditions studied

Decision Support Systems, Clinical — all drugs for Decision Support Systems, Clinical →

Sponsor

Center of Personalized Medicine, Pirogova — full company profile →

Who can join

18 and older, any sex, with Decision Support Systems, Clinical. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study compares two approaches of upfront chemotherapy in breast cancer.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Decision Support Systems, Clinical

Currently open trials in the same condition.

NCT07352475 — Reasoning Enrichment With Feedback From IA in NEphrology Trial · NA · recruiting
NCT07167927 — Developing an Innovative Decision Support Tool for Pediatric Neuromuscular Scoliosis · NA · recruiting
NCT06847906 — Evaluating the Reach of Clinical Decision Support for Patients With Heart Failure · NA · recruiting

Other Center of Personalized Medicine, Pirogova trials

Trials by the same sponsor.

NCT04798976 — Personalized Evidence-based Treatment in Patients With Invasive Breast Cancer · unknown
NCT04791046 — Antihypertensive Therapy in Patients With Comorbidities · unknown
NCT04774341 — Personalized Evidence-based Medicine in Patients With Atrial Fibrillation · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04802941 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Center of Personalized Medicine, Pirogova
Last refreshed: 18 March 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04802941.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing